Metis Global Partners LLC Has $1.76 Million Holdings in Omega Healthcare Investors, Inc. $OHI

Metis Global Partners LLC lifted its position in Omega Healthcare Investors, Inc. (NYSE:OHI) by 34.3% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 47,948 shares of the real estate investment trust’s stock after acquiring an additional 12,257 shares during the quarter. Metis Global Partners LLC’s holdings in Omega Healthcare Investors were worth $1,757,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in OHI. Vanguard Group Inc. raised its stake in Omega Healthcare Investors by 3.9% during the 1st quarter. Vanguard Group Inc. now owns 39,554,886 shares of the real estate investment trust’s stock valued at $1,506,250,000 after purchasing an additional 1,492,904 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in shares of Omega Healthcare Investors by 2.9% during the first quarter. Charles Schwab Investment Management Inc. now owns 4,100,891 shares of the real estate investment trust’s stock valued at $156,162,000 after buying an additional 114,665 shares in the last quarter. Dimensional Fund Advisors LP raised its position in Omega Healthcare Investors by 4.3% during the first quarter. Dimensional Fund Advisors LP now owns 4,058,107 shares of the real estate investment trust’s stock valued at $154,533,000 after buying an additional 165,554 shares during the period. Bank of New York Mellon Corp raised its position in Omega Healthcare Investors by 12.8% during the second quarter. Bank of New York Mellon Corp now owns 3,522,082 shares of the real estate investment trust’s stock valued at $129,084,000 after buying an additional 398,930 shares during the period. Finally, AQR Capital Management LLC lifted its stake in Omega Healthcare Investors by 430.8% in the 1st quarter. AQR Capital Management LLC now owns 2,862,117 shares of the real estate investment trust’s stock worth $108,989,000 after acquiring an additional 2,322,878 shares in the last quarter. 65.25% of the stock is currently owned by hedge funds and other institutional investors.

Omega Healthcare Investors Stock Up 1.0%

Shares of Omega Healthcare Investors stock opened at $43.96 on Tuesday. The firm has a market cap of $12.99 billion, a price-to-earnings ratio of 27.14, a P/E/G ratio of 1.85 and a beta of 0.69. The stock has a 50-day simple moving average of $41.55 and a 200-day simple moving average of $39.33. Omega Healthcare Investors, Inc. has a 52-week low of $35.04 and a 52-week high of $44.21. The company has a debt-to-equity ratio of 0.96, a current ratio of 7.10 and a quick ratio of 7.10.

Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings data on Thursday, October 30th. The real estate investment trust reported $0.79 EPS for the quarter, topping analysts’ consensus estimates of $0.77 by $0.02. The firm had revenue of $260.74 million for the quarter, compared to the consensus estimate of $262.48 million. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The firm’s revenue was up 14.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.71 earnings per share. Omega Healthcare Investors has set its FY 2025 guidance at 3.080-3.100 EPS. On average, equities research analysts expect that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Monday, November 3rd will be issued a dividend of $0.67 per share. The ex-dividend date is Monday, November 3rd. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.1%. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 149.72%.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Scotiabank lifted their target price on Omega Healthcare Investors from $39.00 to $42.00 and gave the company a “sector perform” rating in a research note on Thursday, August 28th. Truist Financial raised their price target on shares of Omega Healthcare Investors from $39.00 to $44.00 and gave the stock a “hold” rating in a report on Wednesday, September 3rd. Wells Fargo & Company boosted their price objective on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the company an “overweight” rating in a research report on Tuesday, October 21st. Raymond James Financial reiterated an “outperform” rating on shares of Omega Healthcare Investors in a research note on Tuesday, September 2nd. Finally, Mizuho lifted their target price on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the company a “neutral” rating in a research note on Thursday, September 11th. Five research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat, Omega Healthcare Investors presently has a consensus rating of “Moderate Buy” and an average price target of $44.29.

Insider Buying and Selling at Omega Healthcare Investors

In other Omega Healthcare Investors news, CIO Vikas Gupta bought 11,500 shares of the stock in a transaction on Thursday, November 6th. The shares were purchased at an average cost of $42.97 per share, with a total value of $494,155.00. Following the completion of the transaction, the executive directly owned 13,773 shares of the company’s stock, valued at $591,825.81. This represents a 505.94% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO C Taylor Pickett bought 20,000 shares of the business’s stock in a transaction on Wednesday, November 5th. The shares were bought at an average price of $43.14 per share, for a total transaction of $862,800.00. Following the completion of the acquisition, the chief executive officer owned 20,000 shares of the company’s stock, valued at approximately $862,800. This represents a ∞ increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 1.50% of the stock is currently owned by insiders.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.